Search

Your search keyword '"Zerbini, Cristiano"' showing total 362 results
Start Over Author "Zerbini, Cristiano" Publication Year Range Last 50 years
362 results on '"Zerbini, Cristiano"'

1. Chronic arthritides and bone structure: focus on rheumatoid arthritis-an update.

Author

Messina, Osvaldo Daniel, Vidal, Maritza, Adami, Giovanni, Vidal, Luis Fernando, Clark, Patricia, Torres, Jorge A Morales, Lems, William, Zerbini, Cristiano, Arguissain, Constanza, Reginster, Jean-Yves, and Lane, Nancy E

Subjects
Bone and Bones, Osteoclasts, Osteoblasts, Humans, Bone Resorption, Arthritis, Rheumatoid, Cytokines, Female, Fractures, Bone, Bone, Bone mass, Fractures, Inflammation, Osteoporosis, Rheumatoid arthritis, Autoimmune Disease, Arthritis, Aging, 2.1 Biological and endogenous factors, Aetiology, Inflammatory and immune system, Musculoskeletal, Clinical Sciences, Public Health and Health Services, Cognitive Sciences, Geriatrics
Abstract

Normal bone remodeling depends of a balance between bone forming cells, osteoblasts and bone resorbing cells, the osteoclasts. In chronic arthritides and some inflammatory and autoimmune diseases such as rheumatoid arthritis, there is a great constellation of cytokines produced by pannus that impair bone formation and stimulate bone resorption by inducing osteoclast differentiation and inhibiting osteoblast maturation. Patients with chronic inflammation have multiple causes that lead to low bone mineral density, osteoporosis and a high risk of fracture including circulating cytokines, impaired mobility, chronic administration of glucocorticoids, low vitamin D levels and post-menopausal status in women, among others. Biologic agents and other therapeutic measures to reach prompt remission might ameliorate these deleterious effects. In many cases, bone acting agents need to be added to conventional treatment to reduce the risk of fractures and to preserve articular integrity and independency for daily living activities. A limited number of studies related to fractures in chronic arthritides were published, and future investigation is needed to determine the risk of fractures and the protective effects of different treatments to reduce this risk.

Published
2023

2. Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update: This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF)

Author

Messina, Osvaldo Daniel, Vidal, Maritza, Torres, Jorge A Morales, Vidal, Luis Fernando, Arguissain, Constanza, Pereira, Rosa María, Clark, Patricia, Cerdas Perez, Sonia, Campusano, Claudia, Lazaretti-Castro, Marise, Zerbini, Cristiano, Scali, Juan J., Mendez Sanchez, Lucia, Peralta-Pedrero, Maria L., Cavallo, Andrea, Valdivia Ibarra, Francisco J., and Hernandez Pérez, Talina

Published
2022
Full Text
View/download PDF

5. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Author

Mautalén, Carlos Alfredo, Man, Zulema, Zanchetta, Jose Ruben, Magaril, Clelia Haydee, Sambrook, Philip, Reginster, Jean-Yves, Geusens, Piet, Goemaere, Stefan, Albergaria, Ben Hur, Zerbini, Cristiano Augusto de Freitas, Castro, Marise Lazaretti, Gregorio, Luiz Henrique, Stoilov, Rumen, Borissova, Anna-Maria I, Hristozov, Kiril Hristov, Temelkova, Nataliya L, Daskalova, Ivona Kirilova, Kuzmanova, Stefka Ivanova, Yaneva-Bichovska, Daniela, Batalov, Anastas Zgurov, Riedemann, Pablo, Rodriguez Portales, José Adolfo, Tang, Hai, Zhu, hanmin, Zhang, Zhenlin, Chao, Aijun, Hu, Yali, Liu, Zhiming, Lu, Juming, Qiu, Mingcai, Gao, Xin, Zhang, Shaofen, Xu, Ling, Xia, Weibo, Liao, Eryuan, Yang, Wenying, Wu, Wen, Dai, Kerong, Hu, Renming, Jaller, Juan Jose, Cabal, Francisco, Molina, José Fernando, Cure Cure, Carlos A, Yupanqui-Lozno, Hernan, Chalem, Philippe, Londono, John, Abello, Mauricio, Tobias, Edgardo D, Otero, William, Nikolic, Tatjana, Miskic, Blazenka, Stepan, Jan, Vyskocil, Vaclav, Novosad, Libor, Slesinger, Jan, Novosad, Pavel, Vlckova, Erika, Bortlik, Ladislav, Dokoupilova, Eva, Hala, Tomas, Jensen, Jens-Erik Beck, Brixen, Kim Torsten, Langdahl, Bente Lomholt, Schwarz, Peter, Eskildsen, Peter Claes, Eiken, Pia Agnete, Hermann, Anne Pernille, Gram, Jeppe, Schou, Maiken Brix, Alexandersen, Peter, Nedergaard, Bettina, Mejía, Dolores Magdalena, Estrella De Henriquez, Lourdes, Páez, Norka, Velazco, Casimiro, Valter, Ivo, Vahula, Kadri-Liina, Kull, Ingrid, Maasalu, Katre, Chapurlat, Roland, Fardellone, Patrice, Benhamou, Claude Laurent, Roux, Christian, Weryha, Georges, Herkt, Volkmar, Martz, Rene, Nischik, Ruth, Spieler, Wolfgang, Contzen, Christel, Felsenberg, Dieter, Frieling, Isolde, Frahm, Eike, Briones, Henry, Sandoval, Boris, Barrios, Patricia, García, Abraham, Avendaño, Carlos, González, Magdalena, Guerra, Jeremías, Tuna, Maria, Díaz, Olga Marina, Samayoa, Eduardo, López, Edgar, Barrera, José Raúl, Palencia, Mainor, Cifuentes, Mayra, Alvarado, Georgina, López, Miriam, Chavez, Nilmo, Haase, Franklin, Rivera, Ruddy, González, Claudio, Tan, Kathryn, Leung, Ping Chung, Mandalam, Sheshadri, Pitale, Shailesh Umakant, Bantwal, Ganapathi, Ammini, Ariachery Chinamma, Shaikh, Shehla Sajid Akhta, Kanakatte Mylariah, Prasanna Kumar, Dharmalingam, Mala, Mukhopadhyay, Satinath, Jain, Arpit, Singh, Parminder, Shetty, Naresh, Sathyanarayana, Srikanta Shamanna, Shah, Nalini, Chadha, Manoj Dharam, Bhandankar, Rajendra, Velayutham, Kumaravel, Marwah, Sudha, John, Mathew, Sahay, Rakesh Kumar, Adami, Silvano, Nuti, Ranuccio, Bianchi, Gerolamo, Brandi, Maria Luisa, Minisola, Salvatore, Fiore, Carmelo Erio, Rubinacci, Alessandro, Miyajima, Hisayuki, Yamane, Hiroo, Nakatani, Yuji, Okamoto, Sumiaki, Kuroda, Koji, Fujimori, Motoaki, Itabashi, Akira, Katayama, Kuniaki, Nakajo, Satoru, Somekawa, Yoshiaki, Ohsawa, Yoshimitsu, Tajima, Wataru, Mizuno, Katsunori, Mori, Shigeru, Kanabuchi, Takato, Hashizume, Hiroyuki, Oka, Nobuyuki, Hamada, Kazutoshi, Yamaguchi, Motoi, Hirahara, Fumiki, Atobe, Masaaki, Ohtake, Yoshiharu, Ichikawa, Shuichi, Onishi, Tomoyuki, Matsumoto, Kou, Nakamura, Tetsuro, Shirasawa, Eishi, Katayama, Ko, Takahashi, Mitsugu, Oguma, Tadanori, Matsui, Hideo, Katoh, Yoshiharu, Shigenobu, Keiichi, Onishi, Tsutomu, Shibukawa, Masato, Ikeda, Satoshi, Osaka, Kazuhiro, Kanda, Ryosuke, Inobe, Yoshito, Shigenobu, Masaharu, Hasegawa, Morimasa, Yamaji, Tetsuo, Miyazaki, Yu, Ito, Takayasu, Nakamura, Eisuke, Nagai, Shinji, Lim, Sung-Kil, Chung, Yoon-Sok, Shin, Chan-Soo, Min, Yong-Ki, Kim, Ghi Su, Yoon, Hyun Koo, Kang, Moo-Il, Yang, Kyu-Hyun, Park, Hyoung Moo, Kim, In Joo, Chung, Dong Jin, Chung, Ho Yeon, Jaundzeikare, Sandra, Andersone, Dace, Medne, Agita, Yaghi, Yasser, Alekna, Vidmantas, Kasiulevicius, Vytautas, Purtokaite - Labutiniene, Irina, Krasauskiene, Aurelija, Varanaviciene, Jurate, Basijokiene, Vida, Abraitiene, Agne, Radzeviciene, Lina, Walliser, Jesus, García Hernández, Pedro Alberto, Araujo, Maria Frida, Avila Armengol, Hilario Ernesto, De la Peña, Pilar, Tamayo, Juan, Zazueta, Beatriz, Cons, Fidencio, Gilchrist, Nigel Leslie, Reid, Ian Reginald, Leikis, Robert, Jones, Peter, Singh, Joe Gragrath Pradeep, Halse, Johan Inge, Syversen, Unni, Høivik, Hans Olav, Øfjord, Erik Snorre, Gulseth, Hans Christian, Elle, Sigbjørn, Norheim, Paal Dag, Calvo Quiroz, Armando A., Cesar Augusto, Pastor A., León Portocarrero, Manuel Gustavo, Vidal Neira, Luis Fernando, Chavez, Jose, Garro Barrera, Boris, Kuroiwa Sampei, Rita, Luis Fernando, Bellatín V., Oquelis Cabredo, Rogger, Castillo, Sonia, Morales, Agustin Miguel G, Tan, Perry Pua, Leagogo, Liberato Antonio C, Jr., Wang, Edward HM, Li-Yu, Julie T, Sawicki, Andrzej Z, Stasiuk, Barbara, Kania, Grzegorz, Lorenc, Roman, Sidorowicz-Bialynicka, Anna, Szczepanski, Leszek, Franek, Edward, Filip, Rafal, Sekula, Jan, Blicharski, Tomasz, Leszczynski, Piotr, Sewerynek, Ewa, Miazgowski, Tomasz, Milewicz, Andrzej, Dabrowska, Magda, Romaszko, Jerzy, Pluskiewicz, Wojciech, Wojnowski, Lukasz, Codreanu, Catalin, Bolosiu, Horatiu, Ionescu, Ruxandra, Zosin, Ioana, Macovei, Liviu, Bojinca, Mihai, Radulescu, Florin, Pop, Simona, Sarbu, Adrian, Benevolenskaya, Lidia I, Nasonov, Evgeny L, Rozhinskaya, Lyudmila Ya, Oganov, Raphael G, Rodionova, Svetlana S, Shlyakhto, Eugeny Vladimirovich, Trofimov, Vasiliy, Zotkin, Eugeny G, Zazerskaya, Irina E, Grineva, Elena N, Ershova, Olga, Lesnyak, Olga, Ostroumova, Olga D, Malichenko, Svetlana B, Pikhlak, Eduard G, Pilyaev, Valery G, Raskina, Tatiana, Zonova, Elena V, Shirinsky, Valery S, Dimic, Aleksandar N, Cobeljic, Goran, Vujovic, Svetlana, Ellis, Graham Charlston, Lipschitz, Stanley, De Villiers, Tobias Johannes, De Weerd, Albert Jan, Vally, Tasneem, Trinder, Yvonne, Coetsee, Jacobus Ludewikus, Davis, Charles Pierre, Nayiager, Savithree, Hough, Frans Stephanus, Oelofse, Louis F, van der Walt, Eugene, Lombaard, Johannes Jurgens, Blignaut, Suzanne, Govind, Uttam, Fouche, Leon Frederik, Kruger, Dawid Stephanus, Dalmeyer, Johannes Paul, Ferreira, Mada M, Escudero-Contreras, Alejandro, Muñoz Torres, Manuel, Hawkins Carranza, Federico, Perez Castrillon, Jose Luis, García Meijide, Juan Antonio, Jodar Gimeno, Esteban, Palacios Gil-Antuñana, Santiago, de Teresa Parreno, Luis, Martín Mola, Emilio, Alvarez Sanchez, Carmen, Lippuner, Kurt, Tsai, Keh-Sung, Tu, Shih-Te, Chen, Jung-Fu, Lee, Oscar Kuang-Sheng, Hsu, Wen-Wei, Grygorieva, Natalia Viktorivna, Povoroznyuk, Vladyslav Volodymyrovych, Korzh, Mykola Oleksiiovych, Loskutov, Oleksandr Levgeniiovych, Chukov, Andriy Borysovych, Sarmiento, Rex, Thomas, Hawys, Donnachie, Hugh, Pavel-Knox, Irina, Shaw, Hilary, Hassanin, Hana, Abdulhakim, Essam Eldin Ahmed, Savani, Naren, Bachmann, Gloria A, Barrett-Connor, Elizabeth, Binkley, Neil C, Bone, Henry G, Brandon, Donald M, Checketts, Darin David, Fraser, Neil J, Watts, Nelson B, Geller, Steven A, Gimbel, Joseph S, Greenwald, Maria White, Holt, Peter A, Johnston, Cyrus Conrad, Fang, Chien, Kiel, Douglas P, Klashman, David J, Lewiecki, E. Michael, Lowenstein, Mitchell B, McClung, Michael Roy, Nattrass, Susan M, Odio, Alberto, Levengood, Julie, Romaguera, Josefina, Saag, Kenneth G, Sebai, Mohamed Bassam, Snyder, Brian, Kutner, Mark Eliot, Streja, Dan, Schwartz, Elliott P, Christiansen, Mark G, McClung, Michael R, O'Donoghue, Michelle L, Papapoulos, Socrates E, Bone, Henry, Langdahl, Bente, Reid, Ian R, Cavallari, Ilaria, Bonaca, Marc P, Wiviott, Stephen D, de Villiers, Tobias, Ling, Xu, Nakamura, Toshitaka, Rodriguez-Portales, Jose Adolfo, Zanchetta, José, Zerbini, Cristiano A F, Park, Jeong-Gun, Im, KyungAh, Cange, Abby, Grip, Laura T, Heyden, Norman, DaSilva, Carolyn, Cohn, Dosinda, Massaad, Rachid, Scott, Boyd B, Verbruggen, Nadia, Gurner, Deborah, Miller, Deborah L, Blair, Micki L, Polis, Adam B, Stoch, S Aubrey, Santora, Arthur, Lombardi, Antonio, Leung, Albert T, Kaufman, Keith D, and Sabatine, Marc S

Published
2019
Full Text
View/download PDF

10. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Author

Kendler, David L, Marin, Fernando, Zerbini, Cristiano A F, Russo, Luis A, Greenspan, Susan L, Zikan, Vit, Bagur, Alicia, Malouf-Sierra, Jorge, Lakatos, Péter, Fahrleitner-Pammer, Astrid, Lespessailles, Eric, Minisola, Salvatore, Body, Jean Jacques, Geusens, Piet, Möricke, Rüdiger, and López-Romero, Pedro

Published
2018
Full Text
View/download PDF

11. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort

Author

Gamboa-Cárdenas, Rocio V, Ugarte-Gil, Manuel F., Loreto, Massardo, Sacnun, Mónica P., Saurit, Verónica, Cardiel, Mario H., Soriano, Enrique R., Pisoni, Cecilia, Galarza-Maldonado, Claudio M., Rios, Carlos, Radominski, Sebastião C., Castelar-Pinheiro, Geraldo da R., Bianchi, Washington Alves, Appenzeller, Simone, da Silveira, Inés Guimarães, de Freitas Zerbini, Cristiano A., Caballero-Uribe, Carlo V., Rojas-Villarraga, Adriana, Guibert-Toledano, Marlene, Ballesteros, Francisco, Montufar, Rubén, Vázquez-Mellado, Janitzia, Esquivel-Valerio, Jorge, De La Torre, Ignacio García, Barile-Fabris, Leonor A., Palezuelos, Fedra Irazoque, Andrade-Ortega, Lilia, Monge, Pablo, Teijeiro, Raquel, Achurra-Castillo, Ángel F., Esteva Spinetti, María H., Alarcón, Graciela S., and Pons-Estel, Bernardo A.

Published
2019
Full Text
View/download PDF

12. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

Author

Austin, Matthew, Yang, Yu‐Ching, Vittinghoff, Eric, Adami, Silvano, Boonen, Steven, Bauer, Douglas C, Bianchi, Gerolamo, Bolognese, Michael A, Christiansen, Claus, Eastell, Richard, Grauer, Andreas, Hawkins, Federico, Kendler, David L, Oliveri, Beatriz, McClung, Michael R, Reid, Ian R, Siris, Ethel S, Zanchetta, Jose, Zerbini, Cristiano AF, Libanati, Cesar, Cummings, Steven R, and Trial, for the FREEDOM

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Osteoporosis, Physical Injury - Accidents and Adverse Effects, Musculoskeletal, Absorptiometry, Photon, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Bone Density, Bone Density Conservation Agents, Denosumab, Double-Blind Method, Female, Fractures, Bone, Humans, Middle Aged, Placebos, Risk Reduction Behavior, Spinal Fractures, DENOSUMAB, BONE MINERAL DENSITY, FRACTURE, SURROGATE, PERCENT OF TREATMENT EFFECT EXPLAINED, FREEDOM Trial, Biological Sciences, Engineering, Medical and Health Sciences, Anatomy & Morphology, Biological sciences, Biomedical and clinical sciences
Abstract

Dual-energy X-ray absorptiometric bone mineral density (DXA BMD) is a strong predictor of fracture risk in untreated patients. However, previous patient-level studies suggest that BMD changes explain little of the fracture risk reduction observed with osteoporosis treatment. We investigated the relevance of DXA BMD changes as a predictor for fracture risk reduction using data from the FREEDOM trial, which randomly assigned placebo or denosumab 60 mg every 6 months to 7808 women aged 60 to 90 years with a spine or total hip BMD T-score < -2.5 and not < -4.0. We took a standard approach to estimate the percent of treatment effect explained using percent changes in BMD at a single visit (months 12, 24, or 36). We also applied a novel approach using estimated percent changes in BMD from baseline at the time of fracture occurrence (time-dependent models). Denosumab significantly increased total hip BMD by 3.2%, 4.4%, and 5.0% at 12, 24, and 36 months, respectively. Denosumab decreased the risk of new vertebral fractures by 68% (p < 0.0001) and nonvertebral fracture by 20% (p = 0.01) over 36 months. Regardless of the method used, the change in total hip BMD explained a considerable proportion of the effect of denosumab in reducing new or worsening vertebral fracture risk (35% [95% confidence interval (CI): 20%-61%] and 51% [95% CI: 39%-66%] accounted for by percent change at month 36 and change in time-dependent BMD, respectively) and explained a considerable amount of the reduction in nonvertebral fracture risk (87% [95% CI: 35% - >100%] and 72% [95% CI: 24% - >100%], respectively). Previous patient-level studies may have underestimated the strength of the relationship between BMD change and the effect of treatment on fracture risk or this relationship may be unique to denosumab.

Published
2012

14. Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis

Author

Radominski, Sebastião Cézar, Bernardo, Wanderley, Paula, Ana Patrícia de, Albergaria, Ben-Hur, Moreira, Caio, Fernandes, Cesar Eduardo, Castro, Charlles H.M., Zerbini, Cristiano Augusto de Freitas, Domiciano, Diogo S., Mendonça, Laura M.C., Pompei, Luciano de Melo, Bezerra, Mailze Campos, Loures, Marco Antônio R., Wender, Maria Celeste Osório, Lazaretti-Castro, Marise, Pereira, Rosa M.R., Maeda, Sergio Setsuo, Szejnfeld, Vera Lúcia, and Borba, Victoria Z.C.

Published
2017
Full Text
View/download PDF

16. Diretrizes brasileiras para o diagnóstico e tratamento da osteoporose em mulheres na pós‐menopausa

Author

Radominski, Sebastião Cezar, Bernardo, Wanderley, Paula, Ana Patrícia de, Albergaria, Ben‐Hur, Moreira, Caio, Fernandes, Cesar Eduardo, Castro, Charlles H.M., Zerbini, Cristiano Augusto de Freitas, Domiciano, Diogo S., Mendonça, Laura M.C., Pompei, Luciano de Melo, Bezerra, Mailze Campos, Loures, Marco Antônio R., Wender, Maria Celeste Osório, Lazaretti‐Castro, Marise, Pereira, Rosa M.R., Maeda, Sergio Setsuo, Szejnfeld, Vera Lúcia, and Borba, Victoria Z.C.

Published
2017
Full Text
View/download PDF

19. Burden of rheumatoid arthritis on patients’ work productivity and quality of life

Author

Xavier, Ricardo Machado, Zerbini, Cristiano Augusto Freitas, Pollak, Daniel Feldman, Morales-Torres, Jorge Luis Alberto, Chalem, Philippe, Restrepo, José Fernando Molina, Duhau, Javier Arnaldo, Amado, Jacqueline Rodríguez, Abello, Maurício, de la Vega, Maria Celina, Dávila, Adriana Pérez, Biegun, Priscila Martin, Arruda, Maysa Silva, and Ramos-Remus, Cesar

Published
2019
Full Text
View/download PDF

22. Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

Author

Thomas, Stephen J, primary, Moreira, Edson D, additional, Kitchin, Nicholas, additional, Absalon, Judith, additional, Gurtman, Alejandra, additional, Lockhart, Stephen, additional, Perez, John L, additional, Marc, Gonzalo Pérez, additional, Polack, Fernando P, additional, Zerbini, Cristiano, additional, Bailey, Ruth, additional, Swanson, Kena A, additional, Xu, Xia, additional, Roychoudhury, Satrajit, additional, Koury, Kenneth, additional, Bouguermouh, Salim, additional, Kalina, Warren V, additional, Cooper, David, additional, Frenck, Robert W, additional, Hammitt, Laura L, additional, Türeci, Özlem, additional, Nell, Haylene, additional, Schaefer, Axel, additional, Ünal, Serhat, additional, Yang, Qi, additional, Liberator, Paul, additional, Tresnan, Dina B, additional, Mather, Susan, additional, Dormitzer, Philip R, additional, Şahin, Uğur, additional, Gruber, William C, additional, and Jansen, Kathrin U, additional

Published
2022
Full Text
View/download PDF

23. Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access

Author

Pavelka, Karel, Akkoç, Nurullah, Al-Maini, Mustafa, Zerbini, Cristiano A. F., Karateev, Dmitry E., Nasonov, Evgeny L., Rahman, Mahboob U., Pedersen, Ronald, Dinh, Andrew, Shen, Qi, Vasilescu, Radu, Kotak, Sameer, Mahgoub, Ehab, and Vlahos, Bonnie

Published
2017
Full Text
View/download PDF

26. Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)

Author

Silva, Barbara C., primary, Madeira, Miguel, additional, d’Alva, Catarina Brasil, additional, Maeda, Sergio Setsuo, additional, Holanda, Narriane Chaves Pereira de, additional, Ohe, Monique Nakayama, additional, Szejnfeld, Vera, additional, Zerbini, Cristiano A. F., additional, Paula, Francisco José Albuquerque de, additional, and Bandeira, Francisco, additional

Published
2022
Full Text
View/download PDF

28. Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort

Author

Gamboa-Cárdenas, Rocio V, Ugarte-Gil, Manuel F., Massardo, Loreto, Sacnun, Mónica P., Saurit, Verónica, Cardiel, Mario H., Soriano, Enrique R., Pisoni, Cecilia, Galarza-Maldonado, Claudio M., Rios, Carlos, Radominski, Sebastião C., Castelar-Pinheiro, Geraldo da R., Bianchi, Washington Alves, Appenzeller, Simone, da Silveira, Inés Guimarães, de Freitas Zerbini, Cristiano A., Caballero-Uribe, Carlo V., Rojas-Villarraga, Adriana, Guibert-Toledano, Marlene, Ballesteros, Francisco, Montufar, Rubén, Vázquez-Mellado, Janitzia, Esquivel-Valerio, Jorge, De La Torre, Ignacio García, Barile-Fabris, Leonor A., Palezuelos, Fedra Irazoque, Andrade-Ortega, Lilia, Monge, Pablo, Teijeiro, Raquel, Achurra-Castillo, Ángel F., Esteva Spinetti, María H., Alarcón, Graciela S., and Pons-Estel, Bernardo A.

Published
2019
Full Text
View/download PDF

29. The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster : Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Author

Boutry, Céline, Hastie, Andrew, Diez-Domingo, Javier, Tinoco, Juan Carlos, Yu, Chong-Jen, Andrews, Charles, Beytout, Jean, Caso, Covadonga, Cheng, Huey-Shinn, Cheong, Hee Jin, Choo, Eun Ju, Curiac, Dan, Di Paolo, Emmanuel, Dionne, Marc, Eckermann, Tamara, Esen, Meral, Ferguson, Murdo, Ghesquiere, Wayne, Hwang, Shinn-Jang, Avelino-Silva, Thiago Junqueira, Kosina, Pavel, Liu, Chiu-Shong, Markkula, Jukka, Moeckesch, Beate, de Oliveira, Cláudia Murta, Park, Dae Won, Pauksens, Karlis, Pirrotta, Paola, Plassmann, Georg, Pretswell, Carol, Rombo, Lars, Salaun, Bruno, Sanmartin Berglund, Johan, Schenkenberger, Isabelle, Schwarz, Tino, Shi, Meng, Ukkonen, Benita, Zahaf, Toufik, Zerbini, Cristiano, Schuind, Anne, Cunningham, Anthony L, Boutry, Céline, Hastie, Andrew, Diez-Domingo, Javier, Tinoco, Juan Carlos, Yu, Chong-Jen, Andrews, Charles, Beytout, Jean, Caso, Covadonga, Cheng, Huey-Shinn, Cheong, Hee Jin, Choo, Eun Ju, Curiac, Dan, Di Paolo, Emmanuel, Dionne, Marc, Eckermann, Tamara, Esen, Meral, Ferguson, Murdo, Ghesquiere, Wayne, Hwang, Shinn-Jang, Avelino-Silva, Thiago Junqueira, Kosina, Pavel, Liu, Chiu-Shong, Markkula, Jukka, Moeckesch, Beate, de Oliveira, Cláudia Murta, Park, Dae Won, Pauksens, Karlis, Pirrotta, Paola, Plassmann, Georg, Pretswell, Carol, Rombo, Lars, Salaun, Bruno, Sanmartin Berglund, Johan, Schenkenberger, Isabelle, Schwarz, Tino, Shi, Meng, Ukkonen, Benita, Zahaf, Toufik, Zerbini, Cristiano, Schuind, Anne, and Cunningham, Anthony L

Abstract

Efficacy against herpes zoster and immune responses to the adjuvanted recombinant zoster vaccine plateaued at high levels between 5.1 and 7.1 years (mean) post-vaccination, suggesting that its clinical benefit in older adults is sustained for at least 7 years post-vaccination. Background This ongoing follow-up study evaluated the persistence of efficacy and immune responses for 6 additional years in adults vaccinated with the glycoprotein E (gE)-based adjuvanted recombinant zoster vaccine (RZV) at age >= 50 years in 2 pivotal efficacy trials (ZOE-50 and ZOE-70). The present interim analysis was performed after >= 2 additional years of follow-up (between 5.1 and 7.1 years [mean] post-vaccination) and includes partial data for year (Y) 8 post-vaccination. Methods Annual assessments were performed for efficacy against herpes zoster (HZ) from Y6 post-vaccination and for anti-gE antibody concentrations and gE-specific CD4[2+] T-cell (expressing >= 2 of 4 assessed activation markers) frequencies from Y5 post-vaccination. Results Of 7413 participants enrolled for the long-term efficacy assessment, 7277 (mean age at vaccination, 67.2 years), 813, and 108 were included in the cohorts evaluating efficacy, humoral immune responses, and cell-mediated immune responses, respectively. Efficacy of RZV against HZ through this interim analysis was 84.0% (95% confidence interval [CI], 75.9-89.8) from the start of this follow-up study and 90.9% (95% CI, 88.2-93.2) from vaccination in ZOE-50/70. Annual vaccine efficacy estimates were >84% for each year since vaccination and remained stable through this interim analysis. Anti-gE antibody geometric mean concentrations and median frequencies of gE-specific CD4[2+] T cells reached a plateau at approximately 6-fold above pre-vaccination levels. Conclusions Efficacy against HZ and immune responses to RZV remained high, suggesting that the clinical benefit of RZV in older adults is sustained for at least 7 years post-vaccination., Zoster-049 Study Groupopen access

Published
2022
Full Text
View/download PDF

30. Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

Author

Fleischmann, Roy, Schiff, Michael, van der Heijde, Désirée, RamosRemus, Cesar, Spindler, Alberto, Stanislav, Marina, Zerbini, Cristiano A. F., Gurbuz, Sirel, Dickson, Christina, de Bono, Stephanie, Schlichting, Douglas, Beattie, Scott, Kuo, WenLing, Rooney, Terence, Macias, William, and Takeuchi, Tsutomu

Published
2017
Full Text
View/download PDF

31. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

Author

Moreira, Edson D., primary, Kitchin, Nicholas, additional, Xu, Xia, additional, Dychter, Samuel S., additional, Lockhart, Stephen, additional, Gurtman, Alejandra, additional, Perez, John L., additional, Zerbini, Cristiano, additional, Dever, Michael E., additional, Jennings, Timothy W., additional, Brandon, Donald M., additional, Cannon, Kevin D., additional, Koren, Michael J., additional, Denham, Douglas S., additional, Berhe, Mezgebe, additional, Fitz-Patrick, David, additional, Hammitt, Laura L., additional, Klein, Nicola P., additional, Nell, Haylene, additional, Keep, Georgina, additional, Wang, Xingbin, additional, Koury, Kenneth, additional, Swanson, Kena A., additional, Cooper, David, additional, Lu, Claire, additional, Türeci, Özlem, additional, Lagkadinou, Eleni, additional, Tresnan, Dina B., additional, Dormitzer, Philip R., additional, Şahin, Uğur, additional, Gruber, William C., additional, and Jansen, Kathrin U., additional

Published
2022
Full Text
View/download PDF

32. Metodologia para a avaliação da atividade física habitual em homens com 50 anos ou mais

Author

Florindo Alex Antonio, Latorre Maria do Rosario Dias de Oliveira, Jaime Patrícia Constante, Tanaka Tomoe, and Zerbini Cristiano Augusto de Freitas

Subjects
Exercício, Avaliação, Métodos, Questionários, Saúde do idoso, Densidade óssea, Atividade física habitual, Public aspects of medicine, RA1-1270
Abstract

OBJETIVO: Descrever a metodologia de avaliação da atividade física habitual, utilizanda em uma pesquisa em população masculina, por meio de um questionário já validado. MÉTODOS: O questionário de atividade física habitual de Baecke, traduzido para a língua portuguesa e, a seguir, foi realizado o back translation. Em sua versão final o questionário foi aplicado em estudo epidemiológico transversal, realizado com 326 homens com idade igual ou superior a 50 anos. A consistência interna entre as questões foi analisada pelo a de Cronbach e foram calculados os coeficientes de correlação de Spearman entre os escores de atividade física habitual, bem como os coeficientes de correlação parcial, ajustados por idade, índice de massa corporal e escolaridade. RESULTADOS: A consistência interna mostrou-se satisfatória nas magnitudes de atividade física ocupacional e exercícios físicos no lazer. Foram obtidas correlações significativas entre todos os escores de atividades físicas com o escore total de atividade física habitual, independente da idade, escolaridade e índice de massa corporal. CONCLUSÕES: O questionário Baecke mostrou-se um instrumento prático para avaliar a atividade física habitual, aliando rapidez na aplicabilidade e facilidade no entendimento para as respostas, sendo indicado para estudos epidemiológicos no Brasil.

Published
2004

33. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

Author

Thomas, Stephen J., primary, Moreira, Edson D., additional, Kitchin, Nicholas, additional, Absalon, Judith, additional, Gurtman, Alejandra, additional, Lockhart, Stephen, additional, Perez, John L., additional, Pérez Marc, Gonzalo, additional, Polack, Fernando P., additional, Zerbini, Cristiano, additional, Bailey, Ruth, additional, Swanson, Kena A., additional, Xu, Xia, additional, Roychoudhury, Satrajit, additional, Koury, Kenneth, additional, Bouguermouh, Salim, additional, Kalina, Warren V., additional, Cooper, David, additional, Frenck, Robert W., additional, Hammitt, Laura L., additional, Türeci, Özlem, additional, Nell, Haylene, additional, Schaefer, Axel, additional, Ünal, Serhat, additional, Yang, Qi, additional, Liberator, Paul, additional, Tresnan, Dina B., additional, Mather, Susan, additional, Dormitzer, Philip R., additional, Şahin, Uğur, additional, Gruber, William C., additional, and Jansen, Kathrin U., additional

Published
2021
Full Text
View/download PDF

34. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

Author

Brown, Jacques P., primary, Engelke, Klaus, additional, Keaveny, Tony M., additional, Chines, Arkadi, additional, Chapurlat, Roland, additional, Foldes, A. Joseph, additional, Nogues, Xavier, additional, Civitelli, Roberto, additional, De Villiers, Tobias, additional, Massari, Fabio, additional, Zerbini, Cristiano A.F., additional, Wang, Zhenxun, additional, Oates, Mary K., additional, Recknor, Christopher, additional, and Libanati, Cesar, additional

Published
2021
Full Text
View/download PDF

37. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Author

McClung, Michael R, primary, O'Donoghue, Michelle L, additional, Papapoulos, Socrates E, additional, Bone, Henry, additional, Langdahl, Bente, additional, Saag, Kenneth G, additional, Reid, Ian R, additional, Kiel, Douglas P, additional, Cavallari, Ilaria, additional, Bonaca, Marc P, additional, Wiviott, Stephen D, additional, de Villiers, Tobias, additional, Ling, Xu, additional, Lippuner, Kurt, additional, Nakamura, Toshitaka, additional, Reginster, Jean-Yves, additional, Rodriguez-Portales, Jose Adolfo, additional, Roux, Christian, additional, Zanchetta, José, additional, Zerbini, Cristiano A F, additional, Park, Jeong-Gun, additional, Im, KyungAh, additional, Cange, Abby, additional, Grip, Laura T, additional, Heyden, Norman, additional, DaSilva, Carolyn, additional, Cohn, Dosinda, additional, Massaad, Rachid, additional, Scott, Boyd B, additional, Verbruggen, Nadia, additional, Gurner, Deborah, additional, Miller, Deborah L, additional, Blair, Micki L, additional, Polis, Adam B, additional, Stoch, S Aubrey, additional, Santora, Arthur, additional, Lombardi, Antonio, additional, Leung, Albert T, additional, Kaufman, Keith D, additional, Sabatine, Marc S, additional, Mautalén, Carlos Alfredo, additional, Man, Zulema, additional, Zanchetta, Jose Ruben, additional, Magaril, Clelia Haydee, additional, Sambrook, Philip, additional, Geusens, Piet, additional, Goemaere, Stefan, additional, Albergaria, Ben Hur, additional, Zerbini, Cristiano Augusto de Freitas, additional, Castro, Marise Lazaretti, additional, Gregorio, Luiz Henrique, additional, Stoilov, Rumen, additional, Borissova, Anna-Maria I, additional, Hristozov, Kiril Hristov, additional, Temelkova, Nataliya L, additional, Daskalova, Ivona Kirilova, additional, Kuzmanova, Stefka Ivanova, additional, Yaneva-Bichovska, Daniela, additional, Batalov, Anastas Zgurov, additional, Riedemann, Pablo, additional, Rodriguez Portales, José Adolfo, additional, Tang, Hai, additional, Zhu, hanmin, additional, Zhang, Zhenlin, additional, Chao, Aijun, additional, Hu, Yali, additional, Liu, Zhiming, additional, Lu, Juming, additional, Qiu, Mingcai, additional, Gao, Xin, additional, Zhang, Shaofen, additional, Xu, Ling, additional, Xia, Weibo, additional, Liao, Eryuan, additional, Yang, Wenying, additional, Wu, Wen, additional, Dai, Kerong, additional, Hu, Renming, additional, Jaller, Juan Jose, additional, Cabal, Francisco, additional, Molina, José Fernando, additional, Cure Cure, Carlos A, additional, Yupanqui-Lozno, Hernan, additional, Chalem, Philippe, additional, Londono, John, additional, Abello, Mauricio, additional, Tobias, Edgardo D, additional, Otero, William, additional, Nikolic, Tatjana, additional, Miskic, Blazenka, additional, Stepan, Jan, additional, Vyskocil, Vaclav, additional, Novosad, Libor, additional, Slesinger, Jan, additional, Novosad, Pavel, additional, Vlckova, Erika, additional, Bortlik, Ladislav, additional, Dokoupilova, Eva, additional, Hala, Tomas, additional, Jensen, Jens-Erik Beck, additional, Brixen, Kim Torsten, additional, Langdahl, Bente Lomholt, additional, Schwarz, Peter, additional, Eskildsen, Peter Claes, additional, Eiken, Pia Agnete, additional, Hermann, Anne Pernille, additional, Gram, Jeppe, additional, Schou, Maiken Brix, additional, Alexandersen, Peter, additional, Nedergaard, Bettina, additional, Mejía, Dolores Magdalena, additional, Estrella De Henriquez, Lourdes, additional, Páez, Norka, additional, Velazco, Casimiro, additional, Valter, Ivo, additional, Vahula, Kadri-Liina, additional, Kull, Ingrid, additional, Maasalu, Katre, additional, Chapurlat, Roland, additional, Fardellone, Patrice, additional, Benhamou, Claude Laurent, additional, Weryha, Georges, additional, Herkt, Volkmar, additional, Martz, Rene, additional, Nischik, Ruth, additional, Spieler, Wolfgang, additional, Contzen, Christel, additional, Felsenberg, Dieter, additional, Frieling, Isolde, additional, Frahm, Eike, additional, Briones, Henry, additional, Sandoval, Boris, additional, Barrios, Patricia, additional, García, Abraham, additional, Avendaño, Carlos, additional, González, Magdalena, additional, Guerra, Jeremías, additional, Tuna, Maria, additional, Díaz, Olga Marina, additional, Samayoa, Eduardo, additional, López, Edgar, additional, Barrera, José Raúl, additional, Palencia, Mainor, additional, Cifuentes, Mayra, additional, Alvarado, Georgina, additional, López, Miriam, additional, Chavez, Nilmo, additional, Haase, Franklin, additional, Rivera, Ruddy, additional, González, Claudio, additional, Tan, Kathryn, additional, Leung, Ping Chung, additional, Mandalam, Sheshadri, additional, Pitale, Shailesh Umakant, additional, Bantwal, Ganapathi, additional, Ammini, Ariachery Chinamma, additional, Shaikh, Shehla Sajid Akhta, additional, Kanakatte Mylariah, Prasanna Kumar, additional, Dharmalingam, Mala, additional, Mukhopadhyay, Satinath, additional, Jain, Arpit, additional, Singh, Parminder, additional, Shetty, Naresh, additional, Sathyanarayana, Srikanta Shamanna, additional, Shah, Nalini, additional, Chadha, Manoj Dharam, additional, Bhandankar, Rajendra, additional, Velayutham, Kumaravel, additional, Marwah, Sudha, additional, John, Mathew, additional, Sahay, Rakesh Kumar, additional, Adami, Silvano, additional, Nuti, Ranuccio, additional, Bianchi, Gerolamo, additional, Brandi, Maria Luisa, additional, Minisola, Salvatore, additional, Fiore, Carmelo Erio, additional, Rubinacci, Alessandro, additional, Miyajima, Hisayuki, additional, Yamane, Hiroo, additional, Nakatani, Yuji, additional, Okamoto, Sumiaki, additional, Kuroda, Koji, additional, Fujimori, Motoaki, additional, Itabashi, Akira, additional, Katayama, Kuniaki, additional, Nakajo, Satoru, additional, Somekawa, Yoshiaki, additional, Ohsawa, Yoshimitsu, additional, Tajima, Wataru, additional, Mizuno, Katsunori, additional, Mori, Shigeru, additional, Kanabuchi, Takato, additional, Hashizume, Hiroyuki, additional, Oka, Nobuyuki, additional, Hamada, Kazutoshi, additional, Yamaguchi, Motoi, additional, Hirahara, Fumiki, additional, Atobe, Masaaki, additional, Ohtake, Yoshiharu, additional, Ichikawa, Shuichi, additional, Onishi, Tomoyuki, additional, Matsumoto, Kou, additional, Nakamura, Tetsuro, additional, Shirasawa, Eishi, additional, Katayama, Ko, additional, Takahashi, Mitsugu, additional, Oguma, Tadanori, additional, Matsui, Hideo, additional, Katoh, Yoshiharu, additional, Shigenobu, Keiichi, additional, Onishi, Tsutomu, additional, Shibukawa, Masato, additional, Ikeda, Satoshi, additional, Osaka, Kazuhiro, additional, Kanda, Ryosuke, additional, Inobe, Yoshito, additional, Shigenobu, Masaharu, additional, Hasegawa, Morimasa, additional, Yamaji, Tetsuo, additional, Miyazaki, Yu, additional, Ito, Takayasu, additional, Nakamura, Eisuke, additional, Nagai, Shinji, additional, Lim, Sung-Kil, additional, Chung, Yoon-Sok, additional, Shin, Chan-Soo, additional, Min, Yong-Ki, additional, Kim, Ghi Su, additional, Yoon, Hyun Koo, additional, Kang, Moo-Il, additional, Yang, Kyu-Hyun, additional, Park, Hyoung Moo, additional, Kim, In Joo, additional, Chung, Dong Jin, additional, Chung, Ho Yeon, additional, Jaundzeikare, Sandra, additional, Andersone, Dace, additional, Medne, Agita, additional, Yaghi, Yasser, additional, Alekna, Vidmantas, additional, Kasiulevicius, Vytautas, additional, Purtokaite - Labutiniene, Irina, additional, Krasauskiene, Aurelija, additional, Varanaviciene, Jurate, additional, Basijokiene, Vida, additional, Abraitiene, Agne, additional, Radzeviciene, Lina, additional, Walliser, Jesus, additional, García Hernández, Pedro Alberto, additional, Araujo, Maria Frida, additional, Avila Armengol, Hilario Ernesto, additional, De la Peña, Pilar, additional, Tamayo, Juan, additional, Zazueta, Beatriz, additional, Cons, Fidencio, additional, Gilchrist, Nigel Leslie, additional, Reid, Ian Reginald, additional, Leikis, Robert, additional, Jones, Peter, additional, Singh, Joe Gragrath Pradeep, additional, Halse, Johan Inge, additional, Syversen, Unni, additional, Høivik, Hans Olav, additional, Øfjord, Erik Snorre, additional, Gulseth, Hans Christian, additional, Elle, Sigbjørn, additional, Norheim, Paal Dag, additional, Calvo Quiroz, Armando A., additional, Cesar Augusto, Pastor A., additional, León Portocarrero, Manuel Gustavo, additional, Vidal Neira, Luis Fernando, additional, Chavez, Jose, additional, Garro Barrera, Boris, additional, Kuroiwa Sampei, Rita, additional, Luis Fernando, Bellatín V., additional, Oquelis Cabredo, Rogger, additional, Castillo, Sonia, additional, Morales, Agustin Miguel G, additional, Tan, Perry Pua, additional, Leagogo, Liberato Antonio C, additional, Wang, Edward HM, additional, Li-Yu, Julie T, additional, Sawicki, Andrzej Z, additional, Stasiuk, Barbara, additional, Kania, Grzegorz, additional, Lorenc, Roman, additional, Sidorowicz-Bialynicka, Anna, additional, Szczepanski, Leszek, additional, Franek, Edward, additional, Filip, Rafal, additional, Sekula, Jan, additional, Blicharski, Tomasz, additional, Leszczynski, Piotr, additional, Sewerynek, Ewa, additional, Miazgowski, Tomasz, additional, Milewicz, Andrzej, additional, Dabrowska, Magda, additional, Romaszko, Jerzy, additional, Pluskiewicz, Wojciech, additional, Wojnowski, Lukasz, additional, Codreanu, Catalin, additional, Bolosiu, Horatiu, additional, Ionescu, Ruxandra, additional, Zosin, Ioana, additional, Macovei, Liviu, additional, Bojinca, Mihai, additional, Radulescu, Florin, additional, Pop, Simona, additional, Sarbu, Adrian, additional, Benevolenskaya, Lidia I, additional, Nasonov, Evgeny L, additional, Rozhinskaya, Lyudmila Ya, additional, Oganov, Raphael G, additional, Rodionova, Svetlana S, additional, Shlyakhto, Eugeny Vladimirovich, additional, Trofimov, Vasiliy, additional, Zotkin, Eugeny G, additional, Zazerskaya, Irina E, additional, Grineva, Elena N, additional, Ershova, Olga, additional, Lesnyak, Olga, additional, Ostroumova, Olga D, additional, Malichenko, Svetlana B, additional, Pikhlak, Eduard G, additional, Pilyaev, Valery G, additional, Raskina, Tatiana, additional, Zonova, Elena V, additional, Shirinsky, Valery S, additional, Dimic, Aleksandar N, additional, Cobeljic, Goran, additional, Vujovic, Svetlana, additional, Ellis, Graham Charlston, additional, Lipschitz, Stanley, additional, De Villiers, Tobias Johannes, additional, De Weerd, Albert Jan, additional, Vally, Tasneem, additional, Trinder, Yvonne, additional, Coetsee, Jacobus Ludewikus, additional, Davis, Charles Pierre, additional, Nayiager, Savithree, additional, Hough, Frans Stephanus, additional, Oelofse, Louis F, additional, van der Walt, Eugene, additional, Lombaard, Johannes Jurgens, additional, Blignaut, Suzanne, additional, Govind, Uttam, additional, Fouche, Leon Frederik, additional, Kruger, Dawid Stephanus, additional, Dalmeyer, Johannes Paul, additional, Ferreira, Mada M, additional, Escudero-Contreras, Alejandro, additional, Muñoz Torres, Manuel, additional, Hawkins Carranza, Federico, additional, Perez Castrillon, Jose Luis, additional, García Meijide, Juan Antonio, additional, Jodar Gimeno, Esteban, additional, Palacios Gil-Antuñana, Santiago, additional, de Teresa Parreno, Luis, additional, Martín Mola, Emilio, additional, Alvarez Sanchez, Carmen, additional, Tsai, Keh-Sung, additional, Tu, Shih-Te, additional, Chen, Jung-Fu, additional, Lee, Oscar Kuang-Sheng, additional, Hsu, Wen-Wei, additional, Grygorieva, Natalia Viktorivna, additional, Povoroznyuk, Vladyslav Volodymyrovych, additional, Korzh, Mykola Oleksiiovych, additional, Loskutov, Oleksandr Levgeniiovych, additional, Chukov, Andriy Borysovych, additional, Sarmiento, Rex, additional, Thomas, Hawys, additional, Donnachie, Hugh, additional, Pavel-Knox, Irina, additional, Shaw, Hilary, additional, Hassanin, Hana, additional, Abdulhakim, Essam Eldin Ahmed, additional, Savani, Naren, additional, Bachmann, Gloria A, additional, Barrett-Connor, Elizabeth, additional, Binkley, Neil C, additional, Bone, Henry G, additional, Brandon, Donald M, additional, Checketts, Darin David, additional, Fraser, Neil J, additional, Watts, Nelson B, additional, Geller, Steven A, additional, Gimbel, Joseph S, additional, Greenwald, Maria White, additional, Holt, Peter A, additional, Johnston, Cyrus Conrad, additional, Fang, Chien, additional, Klashman, David J, additional, Lewiecki, E. Michael, additional, Lowenstein, Mitchell B, additional, McClung, Michael Roy, additional, Nattrass, Susan M, additional, Odio, Alberto, additional, Levengood, Julie, additional, Romaguera, Josefina, additional, Sebai, Mohamed Bassam, additional, Snyder, Brian, additional, Kutner, Mark Eliot, additional, Streja, Dan, additional, Schwartz, Elliott P, additional, and Christiansen, Mark G, additional

Published
2019
Full Text
View/download PDF

39. Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial

Author

Body, Jean-Jacques, Marin, F., Kendler, David, Zerbini, Cristiano C.A.F., López-Romero, Pedro, Möricke, Rüdiger, Casado, E., Fahrleitner-Pammer, A., Stepan, J.J., Lespessailles, Eric, Minisola, S., Geusens, Piet P M M P., Body, Jean-Jacques, Marin, F., Kendler, David, Zerbini, Cristiano C.A.F., López-Romero, Pedro, Möricke, Rüdiger, Casado, E., Fahrleitner-Pammer, A., Stepan, J.J., Lespessailles, Eric, Minisola, S., and Geusens, Piet P M M P.

Abstract

Summary: FRAX® calculates the 10-year probability of major osteoporotic fractures (MOF), which are considered to have a greater clinical impact than other fractures. Our results suggest that, in postmenopausal women with severe osteoporosis, those treated with teriparatide had a 60% lower risk of FRAX®-defined MOF compared with those treated with risedronate. Introduction: The VERO trial was an active-controlled fracture endpoint clinical trial that enrolled postmenopausal women with severe osteoporosis. After 24 months, a 52% reduction in the hazard ratio (HR) of clinical fractures was reported in patients randomized to teriparatide compared with risedronate. We examined fracture results restricted to FRAX®-defined major osteoporotic fractures (MOF), which include clinical vertebral, hip, humerus, and forearm fractures. Methods: In total, 1360 postmenopausal women (mean age 72.1 years) were randomized to receive subcutaneous daily teriparatide (20 μg) or oral weekly risedronate (35 mg). Patient cumulative incidence of ≥ 1 FRAX®-defined MOF and of all clinical fractures were estimated by Kaplan-Meier analyses, and the comparison between treatments was based on the stratified log-rank test. Additionally, an extended Cox model was used to estimate HRs at different time points. Incidence fracture rates were estimated at each 6-month interval. Results: After 24 months, 16 (2.6%) patients in the teriparatide group had ≥ 1 low trauma FRAX®-defined MOF compared with 40 patients (6.4%) in the risedronate group (HR 0.40; 95% CI 0.23–0.68; p = 0.001). Clinical vertebral and radius fractures were the most frequent FRAX®-defined MOF sites. The largest difference in incidence rates of both FRAX®-defined MOF and all clinical fractures between treatments occurred during the 6- to 12-month period. There was a statistically significant reduction in fractures between groups as early as 7 months for both categories of clinical fractures analyzed. Conclusion: In postmenopausal women wi, SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2020

40. Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making

Author

Taylor,Peter C, Betteridge,Neil, Brown,T Michelle, Woolcott,John, Kivitz,Alan J, Zerbini,Cristiano, Whalley,Diane, Olayinka-Amao,Oyebimpe, Chen,Connie, Dahl,Palle, Ponce de Leon,Dario, Gruben,David, Fallon,Lara, Taylor,Peter C, Betteridge,Neil, Brown,T Michelle, Woolcott,John, Kivitz,Alan J, Zerbini,Cristiano, Whalley,Diane, Olayinka-Amao,Oyebimpe, Chen,Connie, Dahl,Palle, Ponce de Leon,Dario, Gruben,David, and Fallon,Lara

Abstract

Peter C Taylor, 1 Neil Betteridge, 2 T Michelle Brown, 3 John Woolcott, 4 Alan J Kivitz, 5 Cristiano Zerbini, 6 Diane Whalley, 7 Oyebimpe Olayinka-Amao, 3 Connie Chen, 8 Palle Dahl, 9 Dario Ponce de Leon, 10 David Gruben, 11 Lara Fallon 12 1Botnar Research Centre, University of Oxford, Oxford, UK; 2Neil Betteridge Associates, London, UK; 3Patient-Centered Outcomes Assessment Group, RTI Health Solutions, Research Triangle Park, NC, USA; 4Patient and Health Impact, Health Economics and Outcomes Research, Pfizer Inc, Collegeville, PA, USA; 5Altoona Center for Clinical Research, Duncansville, PA, USA; 6Department of Rheumatology, Centro Paulista De Investigação Clinica, São Paulo, Brazil; 7Patient-Centered Outcomes Assessment Group, RTI Health Solutions, Manchester, UK; 8Xeljanz, Rheumatology, Inflammation & Immunology Medical Affairs, Pfizer Inc, New York, NY, USA; 9Medical Affairs, International Developed Markets, Inflammation & Immunology, Pfizer Inc, Ballerup, Denmark; 10Medical Affairs Latin-America, Pfizer Inc, New York, NY, USA; 11Statistical Research and Data Science Center, Pfizer Inc, Groton, CT, USA; 12Global Medical Affairs, Pfizer Inc, Montreal, QC, CanadaCorrespondence: Peter C TaylorBotnar Research Centre, University of Oxford, Windmill Road, Headington, Oxford OX3 7LD, UKTel +441865 227323Email peter.taylor@kennedy.ox.ac.ukPurpose: Current knowledge of the reasons for patients’ preference for rheumatoid arthritis (RA) treatment modes is limited. This study was designed to identify preferences for four treatment modes, and to obtain in-depth information on the reasons for these preferences.Patients and Methods: In this multi-national, cross-sectional, qualitative study, in-depth interviews were conducted with adult patients with RA in the United States, France, Germany, Italy, Spain, Switzerland, the United Kingdom, and Brazil. Patients’ strength of preference was evaluated using a 100-p

Published
2020

43. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study

Author

Yang, Yue, primary, Xu, Jianhua, additional, Xu, Jian, additional, Li, Xingfu, additional, Hu, Jiankang, additional, Li, Xiangpei, additional, Zhang, Xiao, additional, He, Dongyi, additional, Bao, Chunde, additional, Li, Zhijun, additional, Wang, Guochun, additional, Zerbini, Cristiano A. F., additional, Spindler, Alberto J., additional, Kannowski, Carol L., additional, Wu, Hanjun, additional, Ji, Fei, additional, Zhan, Lujing, additional, Liu, Mengru, additional, and Li, Zhanguo, additional

Published
2021
Full Text
View/download PDF

44. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Author

Polack, Fernando P., primary, Thomas, Stephen J., additional, Kitchin, Nicholas, additional, Absalon, Judith, additional, Gurtman, Alejandra, additional, Lockhart, Stephen, additional, Perez, John L., additional, Pérez Marc, Gonzalo, additional, Moreira, Edson D., additional, Zerbini, Cristiano, additional, Bailey, Ruth, additional, Swanson, Kena A., additional, Roychoudhury, Satrajit, additional, Koury, Kenneth, additional, Li, Ping, additional, Kalina, Warren V., additional, Cooper, David, additional, Frenck, Robert W., additional, Hammitt, Laura L., additional, Türeci, Özlem, additional, Nell, Haylene, additional, Schaefer, Axel, additional, Ünal, Serhat, additional, Tresnan, Dina B., additional, Mather, Susan, additional, Dormitzer, Philip R., additional, Şahin, Uğur, additional, Jansen, Kathrin U., additional, and Gruber, William C., additional

Published
2020
Full Text
View/download PDF

46. Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four–month phase III randomized radiographic study

Author

van der Heijde, Désirée, Tanaka, Yoshiya, Fleischmann, Roy, Keystone, Edward, Kremer, Joel, Zerbini, Cristiano, Cardiel, Mario H., Cohen, Stanley, Nash, Peter, Song, Yeong-Wook, Tegzová, Dana, Wyman, Bradley T., Gruben, David, Benda, Birgitta, Wallenstein, Gene, Krishnaswami, Sriram, Zwillich, Samuel H., Bradley, John D., and Connell, Carol A.

Published
2013
Full Text
View/download PDF

47. Past and present habitual physical activity and its relationship with bone mineral density in men aged 50 years and older in Brazil

Author

Florindo, Alex A., Latorre, Maria do Rosario D.O., Jaime, Patricia C., Tanaka, Tomoe, Pippa, Maria G.B., and Zerbini, Cristiano A.F.

Subjects
Gerontology -- Research, Exercise -- Physiological aspects, Bones -- Density, Health, Seniors
Abstract

Background. The aim of this study was to determine the relationship between habitual physical activity (HPA) during life and bone mineral density (BMD) in men aged 50 years and older. Methods. A total of 326 men aged 50 years and older, volunteers living in Sao Paulo city, Brazil, were studied. BMD was measured in the whole body, femoral neck, Ward's triangle, trochanter, and lumbar spine (L2-L4) with a dual-energy x-ray absorptiometer. The HPA data were collected with questionnaires inquiring about physical exercise and occupational physical activity in the past and during the past 12 months and leisure and locomotor physical activity in the preceding 12 months. The relationship between BMD and HPA was analyzed using multiple linear regression models adjusted for age and body mass index (BMI). Results. Practice of physical exercise in the past 10-20 years and leisure and locomotor physical activity in the preceding 12 months showed a significant positive correlation with BMD of whole body, femoral neck, trochanter, and lumbar spine, and this association was independent of age and BMI. Conclusions. HPA can contribute to preserving BMD in men aged 50 years and older in Brazil, when it is practiced in the past 10-20 years and even in the present.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results